Skeptic Ginger
Nasty Woman
- Joined
- Feb 14, 2005
- Messages
- 96,955
I got the flu shot last winter, and since then I have been falling asleep every night. I just get so tired around 11 pm...
I got the flu shot last winter, and since then I have been falling asleep every night. I just get so tired around 11 pm...
But you don't know that. Who do you think they reported the data to? Was it a coincidence and these doctors just happened to be the researchers interested in publishing a paper?
No, the doctors who first saw these patients would very likely be unrelated to the research project. The doctors who saw the patients would have reported the incidents and that's how the researchers eventually obtained the data.
With such an extremely rare potential side effect and a potentially deadly vaccine preventable disease, it is irresponsible to start ringing alarm bells on such a paucity of data.
I believe that is a misconstrued comment. There are rules about publishing material that has been previously published. But leaks and news reports are not the issue, copyright law is.
I didn't read any such thing. I read that the news media would screw up the information if given snippets and the professional community would then not have the actual data to confirm or refute the news media nonsense.
This should be examined as a separate issue. I need more data before knowing what this is about. All we have are rumors or one kind or another.
Mirrorglass, if the system of pharmaceutical safety relied on some off chance a researcher was interested in a paper on a topic, it would be a pretty inconsistent system.
So you are mistaken on two counts. One, that authorities would be relying on this kind of reporting. But more importantly, what I already said, there is no imminent danger issue here. You are seriously overreacting. You don't go jumping the gun on this kind of data or research. You are talking about an extremely thin connection here and expecting these researchers to sound some alarm?
Similar things are found in studies all the time and no one would expect the researchers to be acting like they uncovered some potentially fatal danger that required immediate alarm bells be sounded. Science is just not that exact and this is a very inexact example.
I think you have a misconception here.
Once more, there is no issue here. It's a handful of narcoleptic cases out of millions and millions of vaccine doses. If anything, blocking a product's market on such flimsy evidence is the outrage. While it may be prudent if one product is riskier than alternative products, but it may also be doing tremendous additional damage convincing the public the flu vaccine is dangerous and unnecessary.
So there's an outbreak of a disease known to be a contributing factor to narcolepsy (according to the article in the OP). A vaccination program is started. Narcolespy cases increase. Therefore it must have been the vaccine? Perhaps I'm missing something, but that doesn't seem to be the obvious conclusion to jump to.
European Medicines Agency recommends restricting use of Pandemrix
The CHMP considered that the epidemiological studies relating to Pandemrix in Finland and Sweden were well designed and the results show an association between Pandemrix vaccination and narcolepsy in children and adolescents in those countries. The results indicate a six- to 13-fold increased risk of narcolepsy with or without cataplexy in vaccinated as compared with unvaccinated children and adolescents, corresponding to about an additional three to seven cases in every 100,000 vaccinated subjects. This risk increase has not been found in adults (older than 20 years). A similar risk has not been confirmed but cannot be ruled out in other countries.
The Committee noted that the vaccine is likely to have interacted with genetic or environmental factors which might raise the risk of narcolepsy, and that other factors may have contributed to the results. There are several initiatives being developed across the EU to further investigate this association.
The CHMP noted that similar epidemiological studies have not been completed in other countries. The preliminary results of the VAESCO study confirmed the signal in Finland. Results are still preliminary and do not allow conclusions in other countries (where vaccination coverage with Pandemrix was lower), but the final results of the VAESCO study are still awaited.
Exposure to specific infectious diseases (including H1N1) at different ages, particularly upper respiratory infections, may have contributed to the observations in the Nordic area. The CHMP considered that it would be helpful if ongoing epidemiological studies seek to address this question.
Exposure to specific infectious diseases (including H1N1) at different ages, particularly upper respiratory infections, may have contributed to the observations in the Nordic area. The CHMP considered that it would be helpful if ongoing epidemiological studies seek to address this question.
The results indicate a six- to 13-fold increased risk of narcolepsy with or without cataplexy in vaccinated as compared with unvaccinated children and adolescents, corresponding to about an additional three to seven cases in every 100,000 vaccinated subjects.
The European Medicines Agency has linked the swine flu vaccine Pandemrix to narcolepsy, backing the results of Finnish and Swedish research.
You must be aware that there were two different types of vaccines. One contained the full amount of antigen to trigger immune response, the other contained 30%-50% of antigene plus an aluminium phosphate based "immune booster" substance. When the vaccine was distributed during the swine flue epidemy, the safety studies for that booster were far from being completed in all patient populations. In particular it was not known to which extent auto immune diseases would be "boostered" in parallel or would become apparent for the first time, mainly in younger patients. The producers obliged the governments of all countries were the boostered vaccine was distributed to keep them free from all civil or criminal liabilties. The full vaccine was sold in the USA and France, the boostered one in Germany and some other countries, which I am not aware of in detail. My choice and advice (as a German physician) was: take the flue. The symptoms you refer to might be related to that agent, as similar symptoms are known since long time: http://www.whale.to/vaccine/west_edda.html
That website is a completely discredited unscientific source of bad medicine/bad science. The sources they cite are no more than opinion and fear mongering pieces.....similar symptoms are known since long time: http://www.whale.to/vaccine/west_edda.html
Yes.Haven't Aluminium salts been used as adjuvants for decades ?
I should point out that this finding was described in 1998 and in the ensuing decade nothing has come of the finding.Macrophagic Myofascitis
Macrophagic myofascitis (MMF) is a term that is used to describe some findings that have been seen microscopically in some muscle biopsies. The lesions are thought to be caused by tissue changes resulting from the normal immune response to the aluminum-adsorbed vaccine.9
The biopsy findings were originally described in a group of French adult patients who had muscle and joint aches and pains and fatigue.10 Although France is the exception, biopsies of muscle are not usually performed on muscles of the arm because that is where vaccines and other shots are often given. In addition, because muscle biopsies are quite painful, muscle biopsies are not performed on normal people—that is, there are no normal control muscle biopsies with which to compare the French patients’ biopsies.
Although the physician who first described the biopsy findings proposed that the aluminum-containing vaccines caused the symptoms in his patients10, most scientists believe that the tissue findings showed the normal response to the aluminum adjuvant; and many felt that the patients’ illnesses did not warrant the performance of a muscle biopsy.11
We have reviewed evidence of adverse events after exposure to aluminium-containing vaccines against diphtheria, tetanus, and pertussis (DTP), alone or in combination, compared with identical vaccines, either without aluminium or containing aluminium in different concentrations. The study is a systematic review with meta-analysis. We searched the Cochrane Vaccines Field Register, the Cochrane Library, Medline, Embase, Biological Abstracts, Science Citation Index, and the Vaccine Adverse Event Reporting System website for relevant studies. Reference lists of retrieved articles were scanned for further studies. We included randomised and semi-randomised trials and comparative cohort studies if the report gave sufficient information for us to extract aluminium concentration, vaccine composition, and safety outcomes. Two reviewers extracted data in a standard way from all included studies and assessed the methodological quality of the studies. We identified 35 reports of studies and included three randomised trials, four semi-randomised trials, and one cohort study. We did a meta-analysis of data from five studies around two main comparisons (vaccines containing aluminium hydroxide vs no adjuvant in children aged up to 18 months and vaccines containing different types of aluminium vs no adjuvants in children aged 10–16 years). In young children, vaccines with aluminium hydroxide caused significantly more erythema and induration than plain vaccines (odds ratio 1·87 [95% Cl 1·57–2·24]) and significantly fewer reactions of all types (0·21 [0·15–0·28]). The frequencies of local reactions of all types, collapse or convulsions, and persistent crying or screaming did not differ between the two cohorts of the trials. In older children, there was no association between exposure to aluminium-containing vaccines and onset of (local) induration, swelling, or a raised temperature, but there was an association with local pain lasting up to 14 days (2·05 [1·25–3·38]). We found no evidence that aluminium salts in vaccines cause any serious or long-lasting adverse events. Despite a lack of good-quality evidence we do not recommend that any further research on this topic is undertaken.
My choice and advice (as a German physician) was: take the flue.